Buprenorphrine: demonstration of physical dependence liability

Area of Science:

• Pharmacology
• Neuroscience
• Addiction Research

Background:

• Buprenorphine is an opiate partial agonist with a complex pharmacological profile.
• Its capacity to produce physical dependence is a critical aspect of its clinical use and abuse potential.

Purpose of the Study:

• To evaluate the dependence-producing potential of buprenorphine in a preclinical model.
• To investigate the influence of morphine substitution on buprenorphine-induced withdrawal.

Main Methods:

• Rats were chronically administered buprenorphine for four days.
• Withdrawal signs were assessed upon drug cessation and naloxone challenge.
• Morphine substitution was employed to precipitate withdrawal.

Main Results:

• Chronic buprenorphine treatment led to weak withdrawal signs upon cessation or naloxone challenge.
• Tolerance to buprenorphine developed within the treatment period.
• Morphine substitution, even after a delay, precipitated more intense withdrawal, which was sensitive to naloxone.

Conclusions:

• Buprenorphine, like other opioids, induces physical dependence.
• The limited withdrawal signs in direct tests are likely due to slow drug-receptor dissociation.
• The maximum dependence induced by buprenorphine is limited compared to pure opioid agonists.